,ESR1

Tommaso De Marchi1, Chun-Fui Lai2, Georgia M Simmons2

  • 1Division of Surgery, Oncology, and Pathology, Department of Clinical Sciences, Lund University, Solvegatan 19, 22362, Lund, Sweden. tommaso.de_marchi@med.lu.se.

Scientific reports
|March 23, 2024
PubMed
概括

乳腺癌中的雌激素受体 (ER) 突变驱动了扩散和对内分泌治疗的耐药性. 这项研究揭示了ER突变细胞的蛋白质变化,包括免疫信号通路的丰富,证实了它们的雌激素独立生长.